https://sante.gouv.fr/IMG/pdf/dgs-urgent_n2025-23_hepatite_a_national.pdf 2025 France public health guidelines hepatitis a virus snacks health planning guidelines infectious disease, nos recurrence human enterovirus 72 recrudescence
--- http://www.has-sante.fr/jcms/c_2633680/fr/antiviraux-d-action-directe 2016 false false false France French evaluation of the transparency committee adult hepatitis C, chronic drug therapy, combination Sofosbuvir antiviral agents direct acting antivirals daclatasvir Simeprevir ledipasvir, sofosbuvir drug combination dasabuvir drug combinations ombitasvir ritonavir paritaprevir fibrosis, liver risk has patient hepacivirus Infections autoimmune diseases hepatic fibrosis, nos fibrosis hepatitis C virus human enterovirus 72 hepatitis C, chronic business liver cirrhosis socialism patients chronic infectious disease guideline antiviral agents chronic hepatitis, nos health case management hepatitis c virus hepatitis a virus dasabuvir ombitasvir paritaprevir daclatasvir fibrosis commerce patients guideline benzimidazoles fluorenes uridine monophosphate sulfonamides uracil uracil anilides carbamates macrocyclic compounds imidazoles